How the FDA Approves Cancer Drugs Without Knowledge of Benefit.

Share the Truth!
Share on facebook
Facebook
Share on twitter
Twitter
Share on google
Google
  Did you know that the FDA is approving drugs that have never been shown to cure any disease or extend the lives of patients? Yep, sadly that’s the truth and people are dying by the thousands because of it.  One example of a drug approved by the FDA for the “treatment” of breast cancer was later found (once the research studies were actually done) that it was causing cancer stem cells and killing patients faster. Here’s the kicker, this drug is still on the market being given to cancer patients! Many cancer patients are paying a system to use them as test subjects, giving them drugs that have no known benefit and even evidence of harm. This should never be allowed, but when Pharma funds your government and FDA, etc. it will continue to happen as patients are seen as profit generators rather than human beings and children of God.  My heart breaks for those who are battling cancer, this is why I am willing to bring the truth forward, whether I am hated for it or not. Suffering cancer patients DO NOT deserve what is being done to them! Want to know how my office works? Click here!

Related Videos:

It’s Never too Late, Cancer Can Still Be Beat! But it Takes Harnessing the Greatest Power for Healing!

Are Cancer Patients Being Lied to or Mislead by their Doctors? New England Medical Journal Says YES

EAT to Starve Your Cancer!

Resources / References:

A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma https://www.nejm.org/doi/full/10.1056/NEJMoa1308573 The most successful cancer drugs in 2019 https://www.proclinical.com/blogs/2019-3/the-most-successful-cancer-drugs-in-2019 Avastin Doesn’t Benefit Breast Cancer Patients, Study Confirms https://news.yahoo.com/avastin-doesnt-benefit-breast-cancer-patients-study-confirms-213617605.html Lessons of a $618,616 Death https://www.bloomberg.com/news/articles/2010-03-04/lessons-of-a-618-616-death Cancer Drugs Approved on the Basis of a Surrogate End Point and Subsequent Overall Survival https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2463590
Share the Truth!
Share on facebook
Facebook
Share on twitter
Twitter
Share on google
Google

Leave a Reply

Your email address will not be published. Required fields are marked *